Nuechterlein Carole has filed 7 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 5860 shares of Aligos Therapeutics, Inc. ($ALGS) on June 25, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 25, 2025 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 5860 | $0.00 | 5,860.0000 | 3,864,436 | 9999.99% | 0.15% |
| June 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 3,003,855 | 9999.99% | 2.00% |
| Feb. 27, 2024 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | D | Stock Option (Right to Buy) | 15000 | $0.00 | 0.0000 | 3,003,855 | 100.00% | 0.50% |
| Feb. 28, 2024 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 4411 | $0.00 | 4,411.0000 | 3,003,855 | 9999.99% | 0.15% |
| Oct. 25, 2023 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | P | Common Stock | 7933601 | $0.76 | 11,025,941.0000 | 0 | 256.56% | 0.00% |
| Oct. 25, 2023 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | P | Warrant (Right to Buy) | 3966800 | $0.13 | 3,966,800.0000 | 0 | 9999.99% | 0.00% |
| July 20, 2023 | Aligos Therapeutics, Inc. | $ALGS | Nuechterlein Carole | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |